Myant and Coapt: A New Era in Assistive Technology
Myant Corp., a leader in textile computing for healthcare, has partnered with Coapt, a pioneer in neural interface technology. This significant collaboration aims to redefine the landscape of assistive technology, particularly through the development of textile-based electromyography (EMG) interfaces. Their work primarily focuses on creating solutions that enhance the interaction between prosthetic limbs and the human body.
Enhancing Comfort and Control in Prosthetics
The partnership combines Coapt's state-of-the-art EMG intent decoder control systems with Myant's advanced textile technology. This innovative blend promises to produce new devices that provide users with greater comfort, precision, and control when using prosthetics. The improvements made possible by these technologies could lead to advancements in therapies aimed at alleviating phantom limb pain and integrating biofeedback solutions, thus pushing forward Myant's mission to elevate everyday experiences for individuals with unique needs.
Vision for a Seamless Integration
According to Myant's CEO, Tony Chahine, both companies share a mutual vision: to enhance quality of life through the seamless fusion of technology with the human experience. This partnership is set to break new ground in the realms of prosthetics and rehabilitation. They envision a future where assistive technology is not just about regaining functionality but also about promoting comfort and independence in daily life.
Innovative Research and Development
Myant and Coapt have laid out a comprehensive roadmap for future innovations in assistive technologies. This includes exploring applications in virtual and augmented reality for medical therapies, aiming to expand the horizons of patient care. Their collaboration will also encompass funded research initiatives and clinical trials that will delve into the broader effects of their combined technologies on global patient populations.
Achieving Greater Autonomy
Blair Lock, CEO of Coapt, expressed excitement about the potential outcomes, stating that together they are working toward a future where assistive technologies not only restore function but also enhance comfort and autonomy for users. This commitment is set to redefine personal freedom for individuals relying on assistive devices.
Showcasing Innovations at CES 2024
In an effort to showcase their groundbreaking developments, Myant is scheduled to participate in the Consumer Electronics Show (CES) in early January. This event will feature live demonstrations in collaboration with Coapt, designed to facilitate the widespread adoption of next-generation assistive technologies. Myant aims to establish meaningful connections with the global healthcare community to further enhance its innovative solutions.
About Myant
Myant's mission is to enhance quality living for everyone. By leveraging advancements in artificial intelligence, medicine, and advanced materials, Myant aims to provide health, safety, connection, and peace of mind throughout all life stages. They are leading a transformative era where AI technologies bolster human capabilities using textile interfaces that act like a connected second skin, seamlessly integrating into our daily lives.
Transforming Daily Experiences
These innovations promise to enrich daily experiences, promote well-being, ensure safety, and redefine social connections, making healthcare universally accessible. Myant's recent expansion into the European market and the addition of AI expert Dr. Xin Gao as Chief AI Officer in 2024 bloom larger aspirations for future growth.
About Coapt
Founded in 2012 and based in Chicago, Coapt has quickly established itself within the field of prosthetic technology. Their flagship product, Complete Control, is a myoelectric prosthesis control system that has received FDA clearance. This advanced technology allows users to naturally control their prosthetic limbs through sophisticated AI that learns and adapts to their muscle signals, providing highly intuitive control. Coapt boasts compatibility with over 450 prosthetic configurations, making it a versatile choice in the market.
About Textile Computing
Myant's unique approach involves knitting sensors into everyday textiles, creating interfaces that continuously sense and respond to the human body. This innovative model is designed to empower individuals to manage their health proactively, hasten treatment delivery, and cultivate deeper connections with both themselves and their surroundings.
Frequently Asked Questions
What is the partnership between Myant and Coapt about?
The partnership focuses on developing textile-based EMG interfaces to enhance prosthetic limb control and comfort.
How does the collaboration aim to improve prosthetics?
By merging cutting-edge technology from both companies, the collaboration seeks to provide greater precision, comfort, and control for users.
What innovations can we expect from this partnership?
The companies are exploring virtual and augmented reality applications for medical therapies, as well as conducting clinical research on their technologies.
When will Myant showcase its innovations?
Myant will demonstrate its latest technologies at the Consumer Electronics Show (CES) in early January 2024.
What is Myant's mission?
Myant aims to enhance quality of life through advanced textile computing, integrating technology seamlessly into everyday living for all individuals.
